Your browser doesn't support javascript.
loading
Recurrence after primary salivary gland carcinoma: Frequency, survival, and risk factors.
Nachtsheim, Lisa; Jansen, L; Shabli, S; Arolt, C; Quaas, A; Klussmann, J P; Mayer, M; Wolber, P.
Afiliación
  • Nachtsheim L; Department of Otorhinolaryngology - Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, Germany.
  • Jansen L; Department of Otorhinolaryngology - Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, Germany.
  • Shabli S; Department of Otorhinolaryngology - Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, Germany.
  • Arolt C; Institute of Pathology, Medical Faculty, University of Cologne, Cologne, Germany.
  • Quaas A; Institute of Pathology, Medical Faculty, University of Cologne, Cologne, Germany.
  • Klussmann JP; Department of Otorhinolaryngology - Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, Germany.
  • Mayer M; Department of Otorhinolaryngology - Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, Germany.
  • Wolber P; Department of Otorhinolaryngology - Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, Germany.
Head Neck ; 2024 Jul 27.
Article en En | MEDLINE | ID: mdl-39073241
ABSTRACT

BACKGROUND:

Primary salivary gland carcinomas (SGC) are rare neoplasms that present therapeutic challenges especially in recurrent tumors. The aim of this study was to investigate the incidence and distribution of tumor recurrence, associated risk factors, and survival.

METHODS:

This analysis includes data from 318 patients treated for SGC between 1992 and 2020. Survival analysis was performed using the Kaplan-Meier method. Univariate and multivariate analyses were used to identify risk factors associated with recurrence.

RESULTS:

21.7% of the patients developed recurrent disease after a mean of 38.2 months. In multivariate analysis, positive-resection margins, vascular invasion, and tumor localization in the submandibular gland and small salivary glands were independent factors for recurrence. The 5-year overall survival was 67%, the 5-year disease-free survival was 54%.

CONCLUSION:

Tumor recurrence in SGC occurred in one out of five patients. In highly aggressive entities and patients with risk factors, treatment intensification should be considered.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Head Neck Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Head Neck Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Alemania
...